Skip to main content

Medical Treatments: Compensation

Volume 496: debated on Wednesday 9 September 2009

To ask the Secretary of State for Health when his Department last made provision for an ex-gratia payment to a patient group affected by a product dispensed by the NHS. (290683)

The Department provides funding to the following organisations who make ex-gratia payments related to contaminated blood or blood products.

The Macfarlane Trust, which was set up in 1988 to establish a hardship fund to assist haemophiliacs who contracted HIV following treatment with blood products on the national health service.

The Eileen Trust, which was set up in 1993 as a charitable trust to assist people other than those with bleeding disorders, who had contracted HIV through NHS treatment with contaminated blood products.

The Skipton Fund Ltd., which was set up in 2004 as an ex-gratia payment scheme for patients infected with hepatitis C through NHS contaminated blood and blood products, provided the patient was alive on 29 August 2003.

Funding is provided to the Macfarlane Trust and Eileen Trust twice a year. The Skipton Fund receives funding as required during the year.

Details of individual payments to patients are not held centrally by the Department.